Product NDC: | 0179-0015 |
Proprietary Name: | Chlorthalidone |
Non Proprietary Name: | Chlorthalidone |
Active Ingredient(s): | 25 mg/1 & nbsp; Chlorthalidone |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0179-0015 |
Labeler Name: | KAISER FOUNDATION HOSPITALS |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA087180 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090608 |
Package NDC: | 0179-0015-01 |
Package Description: | 100 TABLET in 1 BOTTLE (0179-0015-01) |
NDC Code | 0179-0015-01 |
Proprietary Name | Chlorthalidone |
Package Description | 100 TABLET in 1 BOTTLE (0179-0015-01) |
Product NDC | 0179-0015 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Chlorthalidone |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20090608 |
Marketing Category Name | ANDA |
Labeler Name | KAISER FOUNDATION HOSPITALS |
Substance Name | CHLORTHALIDONE |
Strength Number | 25 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Increased Diuresis [PE],Thiazide-like Diuretic [EPC] |